Navigation Links
Westaim announces 2007 year-end results
Date:2/15/2008

99

Write-down of capital

assets and intangible

assets - 1,210 1,203 1,210

Dilution gain - - (4,525) -

Foreign exchange on

short-term investments - - - (52)

Accounts receivable (4,407) 1,690 (7,190) (320)

Inventories 1,508 (587) 4,128 (838)

Other 1,087 173 (98) (30)

Accounts payable and

accrued liabilities (5,808) (1,504) 1,131 (6,563)

-------------------------------------------------------------------------

Cash used in continuing

operations (5,150) (672) (11,033) (18,551)

Cash used in discontinued

operations (3,462) (6,290) (19,739) (25,703)

-------------------------------------------------------------------------

Cash used in operating

activities (8,612) (6,962) (30,772) (44,254)

-------------------------------------------------------------------------

Investing activities

Capital expenditures (402) (755) (2,376) (6,541)

Capital expenditures

- discontinued operations - (56) - (1,339)

Maturity of short-term

investments - 1,285 46,904 30,594

Purchase of short-term

investments - (17,450) (29,453) (44,039)

Purchase of short-term

investments reclassified

to investments - - (14,400) -

Reclassification of cash

equivalents to investments (16) - (2,650) -

Proceeds on sale of third

party asset-b
'/>"/>

SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
2. Westaim reduces ABCP exposure
3. Westaim announces 2007 third quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
5. The Westaim Corporation update on status of short-term investments
6. Abbott Announces 10.8 Percent Increase in Quarterly Dividend
7. China Holdings Announces Starwood Research Institute Initiates Research Coverage
8. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
9. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
10. Nerites Corporation Announces Closing of Series A Funding Round
11. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...team , , DENVER, Jan. 7 C5 Medi...r of technical ceramics in North America, announce...any as Sales Manager for Orthopaedic and Medical D...development and technical support functions for C5...tion to supporting new product development on a gl...
(Date:1/7/2009)...e, study suggests , , WEDNESDAY, Jan. 7 ...han two hours of "screen time" a day watching TV, ...to be physically fit, a new Australian study finds...me study were more likely to be able to "sit and b...ral fellow at the New South Wales Centre for Overw...
(Date:1/7/2009)... born with cleft lip and palate often have one New... a normal life. For some, this year,s resolution ...ing and philanthropy, members of the American Soci...by demonstrating, "it is better to give than to re... charitable organizations to donate their reconstr...
(Date:1/7/2009)...ericans can,t control the economy, but they can do...hat they should pay for healthcare. Healthcarebl...free pricing data to consumers launches today, and...eed to pay fair prices for healthcare. , , Pri... the same market and provider network, may be thou...
Breaking Medicine News(10 mins):Health News:Dr. Steven Hughes Joins Medical Ceramics Provider: C5 Medical Werks 2Health News:More 'Screen Time' Linked to Poor Fitness in Girls 2Health News:New year brings new hope to children born with cleft lip, palate 2Health News:Healthcarebluebook.com: New Web Site Teaches How to Price Shop 2
...hat causes cervical cancer as it affects the linin...is transmitted sexually.// Merck & Co. Inc.'s hav...lc's has introduced Cervarix, both vaccines, clini...t cervical cancer. The new products with great po...
...ld be damaging to health, but obesity has higher d...ovascular diseases and// certain cancers reducing ...according to a government medical advisor. Ken Sn...stitute for Health and Clinical Excellence, said t...
...ives taken on a long term basis to do away with me... both safe and effective.The study// was published... OCP’s in the market that help to reduce the numbe...study is the first one to contend that it is safe ...
...ted that certain Christmas toys are not safe and c...when 14 toys out of the 15 that// were tested, tur...the prescribed safety limits of 85 decibels. Amo...o be toy guns, which included a mechanical toy mac...
Other Medicine News:Health News:Vaccines For Cervical Cancer Will Soon Be Available In Developing Nations 2Health News:Ways to Fight Childhood Obesity 2Health News:Toy Story Turns Bitter-Christmas Toys, No Music to the Ears! 2
(Date:1/5/2009)...ire-FirstCall/ -- Micromet, Inc.,(Nasdaq: MITI ...roprietary,antibodies for the treatment of cancer...an outlook on key events anticipated for the year ...date on its research and development,programs at ...2009: Update on several preclinical BiTE antibodie...
(Date:12/29/2008)...-USNewswire/ -- The winner of the 2008 Award for E...ed today by Dr. Peter G. Goldschmidt, President an... , The winner of the annual award was the Uni... for its best practice " IND Regulatory and Monito...ced human subjects protection, 2) improved data qu...
(Date:12/17/2008)...nt and validation of non-animal alternative test m...ire/ -- MatTek Corporation today announced that th...sed the scientific validity of the Modified EpiDer...ng. ESAC concluded that the Modified EpiDerm SIT ...ediction of skin irritating and non-irritating tes...
(Date:12/17/2008)...stCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) tod...ent in a,Phase 1-2 dose-escalation clinical trial...st, in castration-resistant prostate cancer patien...Food and Drug Administration (FDA) to,advance to ...en-label, U.S. Phase 1-2 study evaluated prostate ...
Breaking Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EpiDerm's Skin Irritation Test Fully Validated in European Union 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4CeraLyte ORS to Prevent Dehydration from Norovirus Outbreak 9421 1CeraLyte ORS to Prevent Dehydration from Norovirus Outbreak 9421 2Dementia Diagnosis Typically Means Death Within Five Years 9419 1Dementia Diagnosis Typically Means Death Within Five Years 9419 2Xie Lab characterizes niche control of stem cell function 1852 1Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread 9412 1Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread 9412 2Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread 9412 3
...rom first Phase 3 trial presented at ENDO 2007 , ,...en the door for,patient recruitment in Europe , ,M...--,Theratechnologies (TSX: TH) reported today that... TH9507 in HIV-associated,lipodystrophy were prese...ting of the Endocrine Society. The presentation wa...
...s Presented at Society of Nuclear Medicine Annual ...irstCall/ --,Immunomedics, Inc. , a biopharmaceuti...odies to treat cancer and other serious,diseases, ...I study,with the Company,s humanized anti-MUC1 mon...otope, Yttrium-90 (Y-90), in patients with,unresec...
Other Medicine Technology:Theratechnologies: TH9507 Phase 3 Clinical Update 2Theratechnologies: TH9507 Phase 3 Clinical Update 3Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 2Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 3Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 4Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 5
CD / DVD Burner captures still images and full motion video. Up to 50 patient archives allows for multiple cases to be stored for future retrieval. The unit provides software burned to every CD / DVD
LCD monitors.
Camera and light source in one compact "Plug-and-Play" device.
...highly sensitive DR system. It features a 17 x 17-...ral radiographic applications. Versatile and flexi...figurations. , ,With advanced Canon technolog...ent images with reduced dose. The CXDI-40Cs Amorph...
Medicine Products: